Join Meeting Now

Your data is secure and never shared.

Brazil
August 2026

Brazil Cold Chain & Pharma Logistics Market Size, Share & Forecast, By Service Type, Mode of Transport & End-Use Industry, 2025-2032

2032

The Brazil Cold Chain & Pharma Logistics Market worth USD 3.8 billion in 2025 is growing at a CAGR of 8.75% to reach USD 6,836 million by 2032. DHL Supply Chain, Kuehne+Nagel, UPS Healthcare, DSV and CEVA Logistics are the major companies operating in this market.

Report Details

Base Year

2025

Pages

89

Region

Brazil

Author

Ken Research

Product Code
KR-RPT-V02-08171

CHAPTER 1 - MARKET SUMMARY

Market Overview

The Brazil Cold Chain & Pharma Logistics Market connects refrigerated storage, transport, packaging and validated handling capacity with pharmaceutical and perishable-goods demand. Brazil's regulated pharmaceutical market sold 6.07 billion packs in 2024, up 5.2%, across thousands of product presentations. High SKU complexity and temperature-sensitive therapies raise the value of traceability, inventory control and qualified distribution services.

The Southeast remains the principal commercial and logistics corridor because São Paulo, Minas Gerais and Rio de Janeiro combine pharmaceutical production, airports, population density and large distribution networks. Friozem alone reports 1.142 million cubic meters of temperature-controlled warehousing and 196,400 pallet positions across its network, illustrating the scale required to consolidate high-throughput refrigerated flows.

Market Value

USD 3,800 million

2025

Dominant Region

Southeast Brazil

2025

Dominant Segment

Refrigerated Warehousing

2025

Total Number of Players

10

Future Outlook

The Brazil Cold Chain & Pharma Logistics Market is projected to move from USD 3,800 million in 2025 to USD 6,836 million by 2032, equivalent to an 8.75% forecast CAGR. The trajectory represents an acceleration from the 7.89% historical CAGR recorded during 2020-2025. The model assumes sustained outsourcing of refrigerated logistics, increasing pharma complexity, additional temperature-sensitive manufacturing and continuing expansion of export-oriented food chains. At the modeled path, market revenue reaches approximately USD 5,780 million in 2030 and USD 6,286 million in 2031 before crossing USD 6,800 million in 2032.

Growth quality is expected to shift toward validated and technology-intensive services rather than capacity expansion alone. Continuous monitoring requirements, packaging qualification, control-tower visibility and GDP-oriented healthcare services increase revenue per shipment while operators continue expanding multi-temperature infrastructure. Brazil's broader cold-chain sector remains fragmented, with refrigerated storage representing 50.62% of broader cold-chain revenue in 2025. A 2025 pharmaceutical manufacturing expansion in Montes Claros includes a new warehouse and quality-control laboratory, illustrating how domestic production investment creates downstream cold-chain opportunities.

8.75%

Forecast CAGR

$6,836 Mn

2030 Projection

Base Year

2025

Historical Period

2020-2025

Forecast Period

2025-2032

Historical CAGR

7.89%

CHAPTER 2 - SCOPE OF REPORT

Scope of the Market

Click to Explore Interactive Mind Map

CHAPTER 3 - Key Stakeholders

Key Target Audience

Key stakeholders who can leverage from this market analysis for investment, strategy, and operational planning.

Investors

CAGR, utilization, capex intensity, margins, compliance, consolidation, exits, risk

Corporates

freight cost, temperature integrity, inventory turns, SLA, outsourcing, resilience

Government

medicine access, food security, compliance, trade, infrastructure, regional resilience

Operators

warehousing, fleet utilization, monitoring, packaging, labor, energy, quality, routes

Financial institutions

project finance, covenants, utilization, demand stability, capex, collateral, returns

What You'll Gain

  • Market sizing and trajectory
  • Policy and compliance mapping
  • Trade exposure indicators
  • Segment structure and levers
  • Competitive landscape shortlist
  • CEO-grade risk priorities

80+

Pages of insights

CHAPTER 4 - Market Size & Growth

Market Size, Growth Forecast and Trends

This section evaluates the historical market size, analyzes year-over-year growth dynamics, and presents forecast projections supported by market performance indicators and demand-side drivers.

Historical & Projected Market Size ($ Million)

Year-over-Year Growth Rate (%)

Market Value vs Volume Growth (%)

Historical Market Performance (2020-2025)

Historical performance accelerated progressively after 2021, with annual value growth increasing from 6.15% to 9.20% by 2025. The strongest inflection occurred during 2022-2023 as pharmaceutical distribution normalization, higher cold-storage utilization and expanding export flows lifted service revenue. Brazil's transportation, storage and mailing activity expanded 2.1% in 2025, while agriculture grew 11.7%, strengthening the macro demand base for refrigerated logistics.

Forecast Market Outlook (2025-2032)

The market is modeled to expand at an 8.75% CAGR through 2032, with temperature-controlled throughput increasing from approximately 21.8 million tonnes in 2025 to 33.7 million tonnes in 2032. Value growth exceeds modeled physical-volume growth because compliant pharma handling, validated packaging, visibility technology and value-added services command higher revenue per movement. Brazil's official cold-chain trade body indicates more than 15 million cubic meters of relevant regional refrigerated storage capacity, with Brazilian members representing over 55%.

CHAPTER 5 - Market Data

Market Breakdown

The Brazil Cold Chain & Pharma Logistics Market combines rising throughput with an increasing mix of regulated, monitored and value-added services. For CEOs and investors, growth quality depends on utilization, compliance capability, customer mix and the ability to monetize technology above basic storage and transport.

Market Breakdown

Historical Data (2020-2024) • Base Data (2025) • Forecast Data (2026-2032)

Year
Market Size (USD Mn)
YoY Growth (%)
Temperature-Controlled Throughput (Mn tonnes)
Pharmaceutical Packs Sold (Bn)
Agribusiness Exports (USD Bn)
Period
2020$2,600 Mn+-16.2-
$#%
Forecast
2021$2,760 Mn+6.15%17.0-
$#%
Forecast
2022$2,960 Mn+7.25%18.0-
$#%
Forecast
2023$3,210 Mn+8.45%19.25.77
$#%
Forecast
2024$3,480 Mn+8.41%20.46.07
$#%
Forecast
2025$3,800 Mn+9.20%21.8-
$#%
Forecast
2026$4,132 Mn+8.74%23.2-
$#%
Forecast
2027$4,494 Mn+8.76%24.7-
$#%
Forecast
2028$4,887 Mn+8.74%26.3-
$#%
Forecast
2029$5,315 Mn+8.76%28.0-
$#%
Forecast
2030$5,780 Mn+8.75%29.8-
$#%
Forecast
2031$6,286 Mn+8.75%31.7-
$#%
Forecast
2032$6,836 Mn+8.75%33.7-
$#%
Forecast

Temperature-Controlled Infrastructure

over 15 million cubic meters, current Central and South America benchmark. GCCA Brazil members represent more than 55% of the referenced capacity, indicating meaningful scale but continued fragmentation across operators and regions.

Pharmaceutical Packs Sold

6.07 billion packs, 2024 Brazil. Volumes increased 5.2% year on year across 232 pharmaceutical companies, sustaining recurring requirements for distribution, storage, validated transport and monitoring services.

Agribusiness Export Value

USD 169.2 billion, 2025 Brazil. Export volume rose 3.6%, with beef and fresh-fruit flows expanding strongly, increasing demand for reefer capacity, port staging and export-quality temperature control.

CHAPTER 6 - Segmentation

Market Segmentation Framework

Comprehensive analysis across key dimensions providing insights into market structure, customer requirements, shipment economics and distribution patterns.

No of Segments

7

Dominant Segment

Service Type

Fastest Growing Segment

Business Model

Service Type

Refrigerated Warehousing
$%
Refrigerated Transportation
$%
Temperature-Controlled Packaging
$%
Value-Added Pharma Services
$%

Mode of Transport

Road Freight
$%
Air Freight
$%
Ocean Freight
$%
Multimodal Transport
$%

Shipment Flow

Domestic Distribution
$%
Import Logistics
$%
Export Logistics
$%
Clinical and Urgent Shipments
$%

Customer Type

Pharmaceutical Manufacturers
$%
Healthcare Distributors
$%
Hospitals and Clinical Networks
$%
Food and Agribusiness Shippers
$%

End-Use Industry

Pharmaceuticals and Biologics
$%
Meat and Poultry
$%
Fruits and Vegetables
$%
Dairy and Frozen Foods
$%

Business Model

Asset-Based Integrated 3PL
$%
Contract Cold Storage
$%
Dedicated Distribution
$%
Control-Tower Managed Transportation
$%

Geography

Southeast
$%
South
$%
Center-West
$%
North and Northeast
$%

Key Segmentation Takeaways

Comprehensive analysis across all extracted segmentation dimensions providing insights into market structure, customer requirements, utilization economics and distribution patterns.

Service Type

Refrigerated warehousing remains structurally important because customers need staging capacity, inventory buffers and qualified temperature zones before transportation. Refrigerated transportation monetizes geographic distance, while Temperature-Controlled Packaging and Value-Added Pharma Services raise revenue per shipment through validation, kitting, labeling, documentation and higher service-level requirements.

Business Model

Control-Tower Managed Transportation is expected to gain strategic importance as customers shift from isolated storage or freight contracts toward integrated visibility, exception management and compliance accountability. The model requires relatively limited physical assets but stronger technology and network-management capability, creating scalable fee pools for providers able to integrate warehouses, carriers, monitoring devices and customer systems.

CHAPTER 7 - Regional Analysis

Regional Analysis

Brazil ranks among Latin America's largest cold-chain logistics markets and combines significant food-export exposure with the region's largest pharmaceutical manufacturing base. Within the selected peer group, Brazil ranks second by 2025 market value behind Mexico, while its modeled 8.75% CAGR exceeds several mature peer forecasts.

Focus Country Ranking

2nd

Focus Country Market Size

USD 3.8 Bn (2025)

Brazil CAGR (2025-2032)

8.75%

Regional Analysis (Current Year)

Regional Analysis Comparison

MetricBrazilMexicoArgentinaColombiaChile
Market SizeUSD 3.80 BnUSD 7.04 BnUSD 2.30 BnUSD 1.67 BnUSD 0.54 Bn
CAGR (%)8.75%4.90%11.04%6.10%4.09%
Largest Application Share (%)29.05%21.50%-28.41%20.55%
Refrigerated Storage Share (%)50.62%42.20%-47.60%40.35%

Market Position

Brazil ranks 2nd among the five selected markets, supported by pharmaceutical demand and 2025 agribusiness exports of USD 169.2 billion that sustain dense temperature-controlled flows.

Growth Advantage

Brazil's 8.75% modeled CAGR exceeds Mexico's 4.90%, Colombia's 6.10% and Chile's 4.09%, although Argentina's 11.04% published outlook is faster from a smaller base.

Competitive Strengths

Brazil combines a 6.07-billion-pack pharmaceutical market, more than 55% representation of referenced GCCA cold-storage capacity and export corridors spanning proteins, fruit and pharmaceuticals.

CHAPTER 8 - INDUSTRY ANALYSIS

Growth Drivers, Challenges & Opportunities

Comprehensive analysis of key factors shaping the Brazil Cold Chain & Pharma Logistics Market, including growth catalysts, operational challenges, and emerging opportunities across storage, transport, pharmaceutical distribution and perishable-goods segments.

Growth Drivers

Expansion of Temperature-Sensitive Pharmaceutical Demand

  • The regulated market included 232 pharmaceutical companies (2024, Brazil) and 14,586 presentations, increasing SKU complexity and generating demand for multi-temperature inventory, segregation and traceability services.
  • A planned USD 1.09 billion investment (2025, Brazil) by Novo Nordisk includes a 74,000-square-meter production expansion, creating additional injectable-drug and warehouse flows for specialized logistics providers.
  • The expanded facility is scheduled to begin operations in 2028 (Brazil) and Brazil already exports Novo Nordisk products to more than 70 countries, supporting airport, packaging and validated export-lane opportunities.

Record Agrifood Export Throughput

  • Exported agribusiness volume increased 3.6% (2025, Brazil), supporting higher pallet turns and reefer utilization even as average export prices declined 0.6%.
  • Beef export revenue reached USD 17.9 billion (2025, Brazil) and physical volume increased 20.4%, benefiting blast-freezing, cold storage and port-oriented refrigerated transport providers.
  • Fruit export volume increased 19.7% (2025, Brazil), creating additional opportunities for pre-cooling, chilled warehousing, reefer containers and condition-monitoring services along export corridors.

Stricter Temperature and Quality Compliance

  • Updated customs-area requirements introduced continuous temperature monitoring (2024, Brazil) and alarm systems for thermolabile products, supporting demand for sensors, visibility platforms and validated storage.
  • The 2024 framework also requires thermal mapping or qualification (2024, Brazil) of storage areas, increasing entry barriers for low-specification warehouses and supporting specialist operators.
  • Good Storage Practice certification validity was extended to four years (2024, Brazil), giving qualified operators longer certification visibility while maintaining inspection and quality-system obligations.

Market Challenges

Structural Shortage of Qualified Drivers

  • More than 50% of surveyed operators (2026, Brazil) reported severe or very severe recruitment difficulties, limiting fleet growth even where physical vehicles and cargo are available.
  • Road transport carries more than 65% of Brazilian goods by volume (2026, Brazil), making refrigerated networks particularly exposed to driver availability and wage pressure.
  • Only 11% of drivers are under 25 (2026, Brazil) while 24% are 55 or older, implying continued recruitment and training costs for technically demanding refrigerated and high-value cargo operations.

Compliance Capex and Operating Complexity

  • Operators must implement thermal qualification requirements (2024, Brazil) for storage environments, increasing commissioning costs and reducing the competitiveness of basic warehouses without validated refrigeration infrastructure.
  • Pharmaceutical customers faced an average permitted medicine-price adjustment of 3.83% (2025, Brazil), below 5.06% inflation, increasing pressure to control outsourced logistics costs.
  • CMED's 2025 adjustment structure ranged from 2.60% to 5.06% (2025, Brazil) by competition category, reinforcing customer sensitivity to logistics pricing and productivity performance.

Regional Infrastructure Imbalance

  • Friozem reports 1.142 million cubic meters (current, Brazil) across its network, demonstrating the large scale needed to provide reliable multi-region capacity and utilization economics.
  • A single Friozem Rio de Janeiro facility reports 194,000 cubic meters (current, Brazil), illustrating concentration of industrial cold-storage assets in major demand corridors.
  • IRU identifies the South, Southeast and Center-West as the strongest shortage corridors in 2026 (Brazil), precisely where freight demand is highest, intensifying capacity constraints around core cold-chain hubs.

Market Opportunities

Biopharma Manufacturing and GLP-1 Logistics

  • The planned facility spans 74,000 square meters (2025 announcement, Brazil), creating demand for warehouse integration, inbound materials, temperature-controlled distribution and quality-support services.
  • Brazil serves export flows to more than 70 countries (2025, Novo Nordisk Brazil), allowing airfreight, packaging and customs specialists to capture higher-value international healthcare lanes.
  • Operations at the expanded site are expected from 2028 (Brazil), giving logistics investors a defined window to build qualified capacity and customer integrations before incremental output arrives.

Monitoring, Packaging and Control-Tower Services

  • UPS Premier in Brazil provides 24/7 monitoring (2025, Brazil) through dedicated control-tower capability, demonstrating the premium-service model available for critical healthcare shipments.
  • DSV supports multiple controlled zones including +2°C to +8°C and -80°C (current, Brazil), showing how specialized temperature ranges differentiate pharma logistics offerings.
  • FedEx offers healthcare packaging for 2°C to 8°C shipments (current, Brazil), supporting monetization through packaging, insulation and exception-management services beyond line-haul freight.

Export-Corridor and Underserved-Region Expansion

  • New market openings generated approximately USD 4 billion in additional foreign revenue (2023-2025, Brazil), expanding addressable reefer, port and documentation services for logistics operators.
  • Brazil's 2024/2025 grain crop reached 352.2 million tonnes (2025, Brazil), 17% above the prior cycle, supporting broader logistics density and investment around export corridors serving temperature-sensitive categories.
  • SuperFrio explicitly targets regions lacking refrigerated infrastructure, while Brazil's organized capacity benchmark exceeds 15 million cubic meters (current regional reference), supporting selective greenfield and brownfield expansion.

CHAPTER 9 - Competitive Landscape

Competitive Landscape Overview

The market is fragmented across global healthcare logistics specialists and domestic refrigerated operators. Entry barriers arise from validated infrastructure, regulatory compliance, nationwide network density, temperature-monitoring technology and customer-specific quality requirements.

Market Share Distribution

DHL Supply Chain
Kuehne+Nagel
UPS Healthcare
FedEx Logistics

Top 5 Players

1
DHL Supply Chain
!$*
2
Kuehne+Nagel
^&
3
UPS Healthcare
#@
4
FedEx Logistics
$
5
DSV
&@$
Combined Share$%

Market Dynamics

Local Players70%
Regional/Int'l30%

8 new entrants in the past 5 years, indicating strong market attractiveness and growth potential.

Company Profiles (Top 10 Players)
Company Name
Market Share
Headquarters
Founding Year
Core Market Focus
DHL Supply Chain
-Bonn, Germany1969Life sciences contract logistics, temperature-controlled storage and pharmaceutical distribution
Kuehne+Nagel
-Schindellegi, Switzerland1890HealthChain pharma logistics, vaccine distribution and multimodal temperature-controlled freight
UPS Healthcare
-Atlanta, United States1907Time-critical healthcare logistics, temperature monitoring and priority shipment visibility
FedEx Logistics
-Memphis, United States1971Healthcare shipping, temperature-controlled packaging and clinical-trial logistics
DSV
-Hedehusene, Denmark1976GDP-oriented cold-chain transport, pharma warehousing and multimodal healthcare logistics
CEVA Logistics
-Marseille, France2006Pharma and biopharma warehousing, controlled-temperature transport and healthcare control towers
Friozem
---Large-scale temperature-controlled warehousing and refrigerated distribution
SuperFrio
---Multi-temperature storage, refrigerated logistics and regional infrastructure expansion
ARFRIO
---Pharmaceutical logistics, ANVISA-oriented cold storage and refrigerated distribution
Brasfrigo
-Itajaí, Brazil-Cold storage, refrigerated distribution and food-logistics compliance

Cross Comparison Parameters

The report provides detailed cross-comparison of key players across 10 performance parameters to identify competitive strengths and weaknesses.

Analysis Covered

Market Share Analysis:

Benchmarks competitive scale without assigning unsupported private-company market shares.

Cross Comparison Matrix:

Compares capacity, coverage, revenue growth and operating profitability performance.

SWOT Analysis:

Assesses network scale, compliance capabilities, technology and execution vulnerabilities.

Pricing Strategy Analysis:

Evaluates storage, transport and value-added service pricing architecture differences.

Company Profiles:

Reviews market focus, operating footprint and differentiated cold-chain capabilities.

CHAPTER 10 - REPORT TOC

Table of Contents

89Pages
34Chapters
10Companies Profiled
7Segmentation Types

Phase 1
Market Assessment Phase

11

Chapters

Supply-side and competitive intelligence covering market sizing, segmentation, competitive dynamics, regulatory landscape, and future forecasts.

Phase 2
Go-To-Market Strategy Phase

15

Chapters

Entry strategy evaluation, execution roadmap, partner recommendations, and profitability outlook.

Complete Report Coverage

201+ detailed sections covering every aspect of the market

143

Assessment Sections

58

Strategy Sections

CHAPTER 11 - Our Approach

Research Methodology

Desk Research

  • Pharmaceutical sales and pack-volume review
  • Cold-storage capacity and operator mapping
  • Agrifood export flow corridor analysis
  • Temperature-control regulation and compliance review

Primary Research

  • Supply Chain Director interviews conducted
  • Cold Storage Operations Manager interviews
  • Pharma Quality Assurance Manager interviews
  • Refrigerated Fleet Manager interviews conducted

Validation and Triangulation

  • 300 respondent cross-check across value-chain
  • Operator revenue benchmarks independently normalized
  • Capacity and throughput assumptions reconciled
  • Demand-side spend proxies independently tested

CHAPTER 12 - FAQ

FAQs

Still have questions?

Our research team is here to help you find the right solution

Contact Research Team

CHAPTER 13 - Related Research

Explore Related Reports

Expand your market intelligence with complementary research across regions and adjacent markets.

Adjacent Reports

Related markets and complementary research

500+

Market Research Reports

50+

Countries Covered

15+

Industry Verticals

Want the full report and an analyst walkthrough?

Unlock the complete dataset, segmentation cuts, and competitive analysis—plus a discovery call that maps insights to your go-to-market priorities.

;